Table of Contents PART 01: Executive summary PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Market segmentation by material Polymeric stents Metallic stents PART 07: Market segmentation by application Market overview PART 08: Market segmentation by end-user Hospitals ASCs PART 09: Geographical segmentation Bioabsorbable stents market in the Americas Bioabsorbable stents market in EMEA Bioabsorbable stents market in APAC PART 10: Market drivers Increasing prevalence of CADs Growing demand for MI procedures Growing diabetic population PART 11: Impact of drivers PART 12: Market challenges Stringent regulation for approval of devices Threat of substitute products Increasing competition among vendors PART 13: Impact of drivers and challenges PART 14: Market trends Advent of metallic stents Growing popularity of hybrid procedures Alternative use of vascular stents PART 15: Vendor landscape Competitive landscape analysis PART 16: Key vendor analysis Boston Scientific Abbott Laboratories Elixir Medical Kyoto Medical Planning Other prominent vendors PART 17: Appendix List of abbreviations PART 18: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global bioabsorbable stents market 2016-2021 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Global bioabsorbable stents market by material 2016 Exhibit 05: Polymeric stents: Market overview Exhibit 06: Polymeric stents: Products Exhibit 07: Metallic stents: Market overview Exhibit 08: Metallic stents: Products Exhibit 09: Global bioabsorbable stents market by application 2016 Exhibit 10: Global bioabsorbable stents market by end-users 2016 Exhibit 11: Revascularisation procedures in Americas 2006 and 2013 (per 100,000 population) Exhibit 12: Revascularisation procedures in EMEA 2006 and 2013 (per 100,000 population) Exhibit 13: Revascularisation procedures in APAC 2006 and 2013 (per 100,000 population) Exhibit 14: Bioabsorbable stents market: ASCs in Americas Exhibit 15: Bioabsorbable stents market: ASCs in EMEA Exhibit 16: Bioabsorbable stents market: ASCs in APAC Exhibit 17: Americas: Overview of bioabsorbable stents market Exhibit 18: Bioabsorbable stents market in Americas 2016-2021 ($ billions) Exhibit 19: Americas: Market metrics in various countries Exhibit 20: Key takeaway: Bioabsorbable stents market in the US Exhibit 21: EMEA: Overview of bioabsorbable stents market Exhibit 22: Bioabsorbable stents market in EMEA 2016-2021 ($ billions) Exhibit 23: EMEA: Market metrics in various countries Exhibit 24: Key takeaway: Bioabsorbable stents market in the UK Exhibit 25: APAC: Overview of bioabsorbable stents market Exhibit 26: Bioabsorbable stents market in APAC 2016-2021 ($ billions) Exhibit 27: APAC: Market metrics in various countries Exhibit 28: Key takeaway: Bioabsorbable stents market in India Exhibit 29: CHD prevalence by sex and age in US 2015 Exhibit 30: Global prevalence of diabetes 2015 and 2040 (millions) Exhibit 31: Impact of drivers Exhibit 32: Bioabsorbable stents under investigation and trials Exhibit 33: Impact of drivers and challenges Exhibit 34: Competitive structure analysis of global bioabsorbable stents market 2016 Exhibit 35: Competitive landscape analysis of global bioabsorbable stents market 2016 Exhibit 36: Market penetration of various bioabsorbable stents manufacturers globally 2016 Exhibit 37: Strategic factors determining success for leading companies in global bioabsorbable stents market Exhibit 38: Boston Scientific: Strength analysis Exhibit 39: Boston Scientific: Strategy assessment Exhibit 40: Boston Scientific: Opportunity assessment Exhibit 41: Abbott Laboratories: Strength assessment Exhibit 42: Abbott Laboratories: Strategy assessment Exhibit 43: Abbott Laboratories: Opportunity assessment Exhibit 44: Elixir Medical: Strength assessment Exhibit 45: Elixir Medical: Strategy assessment Exhibit 46: Elixir Medical: Opportunity assessment Exhibit 47: Kyoto Medical Planning: Strength assessment Exhibit 48: Kyoto Medical Planning: Strategy assessment Exhibit 49: Kyoto Medical Planning: Opportunity assessment Exhibit 50: Other prominent vendors: Bioabsorbable stents market

Boston Scientific, Abbott Laboratories, Elixir Medical, Kyoto Medical Planning, REVA Medical, Arterial Remodeling Technologies, Tepha, Meril Life Sciences, Amaranth Medical, Arterius.